INSIGHTS ON CLINICAL TRIAL DESIGN

• Elosity's Agile RTSM Build Experience

  Modern RTSM requires agility. Learn how real-time visibility, flexible configuration, and faster amendments help teams execute studies with greater efficiency.

• Busting Through Patient Recruitment Barriers

  Building patient trust fuels engagement, data and technology enable targeted recruitment, and real-time patient identification with consistent support drives scalable enrollment success.

• Designing Successful Cell And Gene Therapy Trials

  Designing cell and gene therapy trials requires specialized strategies to navigate unique complexities, ensuring successful and compliant development.

• Patient Support Solutions For Clinical Trials

  Learn how Greenphire leverages its more than 17 years of experience to deliver the most flexible and comprehensive patient-focused solutions and services.

• Optimizing Pharmacokinetics In Clinical Development

  8/24/2026

  PK tools can do more than model drug behavior — they shape smarter trial designs, better dosing decisions, and lighter burdens on patients. Here's how.

• Choosing The Most Effective Method For Biopharmaceutical Development

  5/2/2025

  Explore how the application of protein assays extend from basic research to the development of cutting-edge therapies, which makes them indispensable in the quest to improve human health.

• The Implications Of Semaglutide's Connect To Increased Risk Of NAION

  2/18/2025

  Explore the implications of a connection between semaglutide and an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION).

• Can Patient Liaison Services Transform Clinical Research Access?

  9/25/2025

  Patients often face invisible hurdles in research. Watch how Patient Liaison services can change the journey for participants, sites, and sponsors, making trials easier to join and stay in.

• Why You Should Include SDOH In Clinical Trial Recruitment

  1/28/2025

  Embrace a broader approach to diversity in clinical trials by addressing social determinants of health and designing inclusive studies that ensure equitable representation and access to all patients.